Recent advances in the treatment of B-cell lymphoma

Por Habermann, Thomas M
Publicado em 2009

Patients With Celiac Disease and B-Cell Lymphoma Have a Better Prognosis Than Those With T-Cell Lymphoma

Por Halfdanarson, Thorvardur R., Rubio–Tapia, Alberto, Ristow, Kay M., Habermann, Thomas M., Murray, Joseph A., Inwards, David J.
Publicado em 2010

If you feed them, they will come: A prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical cent...

Por Segovis, Colin M, Mueller, Paul S, Rethlefsen, Melissa L, LaRusso, Nicholas F, Litin, Scott C, Tefferi, Ayalew, Habermann, Thomas M
Publicado em 2007

Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

Por Advani, Ranjana H., Hong, Fangxin, Horning, Sandra J., Kahl, Brad S., Manola, Judith, Swinnen, Lode J., Habermann, Thomas M., Ganjoo, Kristen
Publicado em 2011

Antioxidant Intake from Fruits, Vegetables and Other Sources and Risk of Non-Hodgkin Lymphoma: The Iowa Women's Health Study

Por Thompson, Carrie A., Habermann, Thomas M., Wang, Alice H., Vierkant, Robert A., Folsom, Aaron R., Ross, Julie A., Cerhan, James R.
Publicado em 2010

The Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) with Everolimus Results in Clinical Responses and Mobilization of CLL Cells into...

Por Zent, Clive S., LaPlant, Betsy R., Johnston, Patrick B., Call, Timothy G., Habermann, Thomas M., Micallef, Ivana N., Witzig, Thomas E.
Publicado em 2010

SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma

Por Chen, Linfeng, Monti, Stefano, Juszczynski, Przemyslaw, Daley, John, Chen, Wen, Witzig, Thomas E., Habermann, Thomas M., Kutok, Jeffery L., Shipp, Margaret A.
Publicado em 2008

FDG-PET Report Interpretation as Predictor of Outcome in Diffuse Large B-Cell Lymphoma Including Analysis of “Indeterminate” Reports

Por Thomas, Alexandra, Gingrich, Roger D., Smith, Brian J., Jacobus, Laura, Ristow, Kay, Allmer, Cristine, Maurer, Matthew J., Habermann, Thomas M., Link, Brian K.
Publicado em 2010

Bevacizumab and CHOP (A-CHOP) in Combination for Patients with Peripheral T-Cell or Natural Killer Cell Neoplasms: An Eastern Cooperative Group Study (E2404)

Por Ganjoo, Kristen, Hong, Fangxin, Horning, Sandra J., Gascoyne, Randy D., Natkunam, Yasodha, Swinnen, Lode J., Habermann, Thomas M., Kahl, Brad S., Advani, Ranjana H.
Publicado em 2013

Maintenance Rituximab After Cyclophosphamide, Vincristine, and Prednisone Prolongs Progression-Free Survival in Advanced Indolent Lymphoma: Results of the Randomized Phase III ECOG...

Por Hochster, Howard, Weller, Edie, Gascoyne, Randy D., Habermann, Thomas M., Gordon, Leo I., Ryan, Theresa, Zhang, Lijun, Colocci, Natalia, Frankel, Stanley, Horning, Sandra J.
Publicado em 2009

Response-Adapted Therapy for Aggressive non-Hodgkin's Lymphomas based on early [18F] FDG-PET Scanning: ECOG-ACRIN Cancer Research Group Study (E3404)

Por Swinnen, Lode J., Li, Hailun, Quon, Andrew, Gascoyne, Randy, Hong, Fangxin, Ranheim, Erik A., Habermann, Thomas M., Kahl, Brad S., Horning, Sandra J., Advani, Ranjana H.
Publicado no Br J Haematol (2015)

Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in The Iowa Women’s Health Study (IWHS) cohort

Por Leal, Alexis D., Thompson, Carrie A., Wang, Alice H., Vierkant, Robert A., Habermann, Thomas M., Ross, Julie A., Mesa, Ruben A., Virnig, Beth A., Cerhan, James R.
Publicado em 2013

Hormonal and Reproductive Factors and Risk of Myeloproliferative Neoplasms in Postmenopausal Women

Por Leal, Alexis D., Thompson, Carrie A., Wang, Alice H., Vierkant, Robert A., Habermann, Thomas M., Ross, Julie A., Mesa, Ruben A., Virnig, Beth A., Cerhan, James R.
Publicado no Cancer Epidemiol Biomarkers Prev (2015)

Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era

Por Nowakowski, Grzegorz S., Maurer, Matthew J., Habermann, Thomas M., Ansell, Stephen M., Macon, William R., Ristow, Kay M., Allmer, Cristine, Slager, Susan L., Witzig, Thomas E., Cerhan, James R.
Publicado em 2010

Activity of Topotecan 21-Day Infusion in Patients with Previously Treated Large Cell Lymphoma: Long-term follow-up of an Eastern Cooperative Oncology Group Study (E5493)

Por Wiernik, Peter H., Li, Hailun, Weller, Edie, Hochster, Howard S., Horning, Sandra J., Nazeer, Tipu, Gordon, Leo I., Habermann, Thomas M., Minniti, Carl J., Shapiro, Gary R., Cassileth, Peter A.
Publicado em 2012

PROGNOSTIC SIGNIFICANCE OF PRETREATMENT SERUM CYTOKINES IN CLASSICAL HODGKIN LYMPHOMA

Por Marri, Preethi Reddy, Hodge, Lucy S., Maurer, Matthew J., Ziesmer, Steven C., Slager, Susan L., Habermann, Thomas M., Link, Brian K., Cerhan, James R., Novak, Anne J., Ansell, Stephen M.
Publicado em 2013

The Clinical Spectrum of Castleman's Disease

Por Dispenzieri, Angela, Armitage, James O., Loe, Matt J, Geyer, Susan M., Allred, Jake, Camoriano, John K., Menke, David M., Weisenburger, Dennis D., Ristow, Kay, Dogan, Ahmet, Habermann, Thomas M.
Publicado em 2012

The mTORC1 Inhibitor Everolimus Combined with R-CHOP-21 for New Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Safety and Efficacy Results of a Phase I and Feasibility Trial NCCT...

Por Johnston, Patrick B., LaPlant, Betsy, McPhail, Ellen, Habermann, Thomas M., Inwards, David J., Micallef, Ivana N., Colgan, Joseph P., Nowakowski, Grzegorz S., Ansell, Stephen M., Witzig, Thomas E.
Publicado no Lancet Haematol (2016)

Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma

Por Thompson, Carrie A., Maurer, Matthew J., Cerhan, James R., Katzmann, Jerry A., Ansell, Stephen M., Habermann, Thomas M., Macon, William R., Weiner, George J., Link, Brian K., Witzig, Thomas E.
Publicado em 2011

A Randomized Phase III Study in Low Grade Lymphoma Comparing Maintenance Anti-CD20 Antibody versus Observation following Induction Therapy: A trial of the ECOG-ACRIN Cancer Researc...

Por Barta, Stefan K., Li, Hailun, Hochster, Howard S., Hong, Fangxin, Weller, Edie, Gascoyne, Randy D., Habermann, Thomas M., Gordon, Leo I., Colocci, Natalia, Bengtson, Elizabeth M, Horning, Sandra J., Kahl, Brad S.
Publicado no Cancer (2016)